Capricor Therapeutics Announces 24-Month HOPE-3 Data On Deramiocel In Duchenne Muscular Dystrophy To Be Presented At World Muscle Society Congress September 29 To October 3

Loading news article.

Capricor Therapeutics Announces 24-Month HOPE-3 Data On Deramiocel In Duchenne Muscular Dystrophy To Be Presented At World Muscle Society Congress September 29 To October 3 | WAPE

Capricor Therapeutics Announces 24-Month HOPE-3 Data On Deramiocel In Duchenne Muscular Dystrophy To Be Presented At World Muscle Society Congress September 29 To October 3

Article summary

Related companies

Analyzed by WAPE AI.

Comments —